The summary is not enough. Check out these tweetorials on
Why did we lose the ability to handle excess uric acid?
What is mendelian randomization and what does it tell us here?
This week, we will discuss the use of renal autologous cell therapy (REACT) in diabetic kidney disease.
This week, we will discuss 2026 KDIGO anemia management in patients with kidney disease
This week, we aim for an INFINITe allograft lifespan. or flozination in kidney transplant.
This week, we will discuss the POTCAST trial. It is a cardiology trial - but potassium belongs to nephrology.
Anju Yadav did a great job on the visual abstract for PERL.
Arun Rajasekaran did a great job. I can’t believe it is his first visual abstract.